Your browser doesn't support javascript.
loading
Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli, Larissa S; Ghadially, Hormas; Barry, Simon T.
Affiliation
  • Carnevalli LS; Early Oncology, Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Ghadially H; Early Oncology, Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Barry ST; Early Oncology, Research and Development, AstraZeneca, Cambridge, United Kingdom.
Front Immunol ; 12: 633685, 2021.
Article in En | MEDLINE | ID: mdl-33953710

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Lymphocytes, Tumor-Infiltrating / Tumor Microenvironment / Myeloid-Derived Suppressor Cells / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Lymphocytes, Tumor-Infiltrating / Tumor Microenvironment / Myeloid-Derived Suppressor Cells / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2021 Type: Article Affiliation country: United kingdom